Citation

BibTex format

@article{Colombo:2024:10.1016/S1470-2045(24)00334-6,
author = {Colombo, N and Biagioli, E and Harano, K and Galli, F and Hudson, E and Antill, Y and Choi, CH and Rabaglio, M and Marme, F and Marth, C and Parma, G and Farinas-Madrid, L and Nishio, S and Allan, K and Lee, YC and Piovano, E and Pardo, B and Nakagawa, S and Mcqueen, J and Zamagni, C and Manso, L and Takehara, K and Tasca, G and Ferrero, A and Tognon, G and Lissoni, AA and Petrella, M and Laudani, ME and Rulli, E and Uggeri, S and Ginesta, MPB},
doi = {10.1016/S1470-2045(24)00334-6},
journal = {LANCET ONCOLOGY},
pages = {1135--1146},
title = {Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial},
url = {http://dx.doi.org/10.1016/S1470-2045(24)00334-6},
volume = {25},
year = {2024}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Colombo,N
AU  - Biagioli,E
AU  - Harano,K
AU  - Galli,F
AU  - Hudson,E
AU  - Antill,Y
AU  - Choi,CH
AU  - Rabaglio,M
AU  - Marme,F
AU  - Marth,C
AU  - Parma,G
AU  - Farinas-Madrid,L
AU  - Nishio,S
AU  - Allan,K
AU  - Lee,YC
AU  - Piovano,E
AU  - Pardo,B
AU  - Nakagawa,S
AU  - Mcqueen,J
AU  - Zamagni,C
AU  - Manso,L
AU  - Takehara,K
AU  - Tasca,G
AU  - Ferrero,A
AU  - Tognon,G
AU  - Lissoni,AA
AU  - Petrella,M
AU  - Laudani,ME
AU  - Rulli,E
AU  - Uggeri,S
AU  - Ginesta,MPB
DO  - 10.1016/S1470-2045(24)00334-6
EP  - 1146
PY  - 2024///
SN  - 1470-2045
SP  - 1135
TI  - Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial
T2  - LANCET ONCOLOGY
UR  - http://dx.doi.org/10.1016/S1470-2045(24)00334-6
VL  - 25
ER  -
Download